Following treatment, score severity of symptoms again:
This refers to the patient whose PEF or FEV1 is 70% or higher, is breathing room air with an oxygen saturation of 95% or more and is clinically feeling improved following standard therapy (inhaled beta 2 agonist, corticosteroids and anticholinergic). These patients may be discharged home. They do need good follow-up and identification of any possible risks for recurrence.
This refers to the patient whose PEF or FEV1 is between 40-69%, has an oxygen saturation between 90-95%, but still has symptoms of moderate or severe asthma following treatment over 4 hours. More evaluation is needed to determine disposition. Consider any significant comorbidities (i.e., insulin-dependent diabetes, COPD, CAD, and pneumonia).
Low-risk patients: these patients are candidates for discharge. They will need good follow-up, detailed home medication instructions, and adequate resources at home.
High-risk patients: a finding of a high-risk factor suggests the benefit of admission:
This refers to the patient whose PEF or FEV1 is between 25-40% and still has symptoms of moderate or severe asthma following treatment over 4 hours. These patients require admission with close monitoring and prolonged bronchodilation. The addition of noninvasive positive pressure ventilations (NIPPV) is useful in these cases to diminish the need for intubation.
This refers to the patient whose PEF or FEV1 is under 25% and has no resolution of symptoms of asthma following treatment over 4 hours. These patients require admission to intensive care and likely advanced airway management with mechanical ventilation. The determination to admit to the ICU is based on certain clinical factors